Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-024141
Filing Date
2021-02-16
Accepted
2021-02-16 16:30:31
Documents
2
Group Members
CALC IV LPCITADEL ADVISORS HOLDINGS LPCITADEL GP LLCCITADEL SECURITIES GP LLCCITADEL SECURITIES LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm214737d7_sc13ga.htm SC 13G/A 183233
2 EXHIBIT 99.1 tm214737d7_ex99-1.htm EX-99.1 16770
  Complete submission text file 0001104659-21-024141.txt   201789
Mailing Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603 312-395-2100
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Subject) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87984 | Film No.: 21639222
SIC: 2836 Biological Products, (No Diagnostic Substances)